Glutamate ionotropic kainate receptor subunit 3 (GluK3), also known as KAR3 or GRIK3, is a low-affinity kainate receptor subunit that plays distinct roles in synaptic transmission and neuronal excitability throughout the central nervous system. Unlike the high-affinity GluK5 subunit, GluK3-containing receptors have different pharmacological and physiological properties that make them unique targets for neurological research.
¶ Gene and Protein Structure
The GRIK3 gene (located on chromosome 1p34) encodes the GluK3 protein, which contains:
- Extracellular N-terminal domain with glutamate binding site
- Three transmembrane domains (M1, M3, M4)
- Intracellular C-terminal tail with PDZ-binding motif
- Alternative splicing produces two isoforms: GluK3-1 and GluK3-2
GluK3 can form:
- Homomeric channels (GluK3/GluK3) - rare in vivo
- Heteromeric channels with GluK2 or GluK4
- Unusually, can also co-assemble with AMPA receptor subunits
¶ Distribution and Localization
| Region |
Expression Pattern |
| Hippocampus |
CA1-CA3 pyramidal neurons, dentate gyrus granule cells |
| Cerebral Cortex |
Layer II-V pyramidal neurons, interneurons |
| Cerebellum |
Granule cells, Purkinje cells |
| Thalamus |
Relay neurons |
| Striatum |
Medium spiny neurons |
| Olfactory Bulb |
Mitral cells, tufted cells |
- Postsynaptic: Primarily extrasynaptic and perisynaptic
- Presynaptic: On axon terminals modulating release
- Somatic: On neuronal cell bodies
GluK3 contributes to:
- Slow excitatory neurotransmission
- Modulation of NMDA receptor activity
- Regulation of GABAergic signaling
- Activity-dependent plasticity
- Controls resting membrane potential
- Modulates action potential threshold
- Influences firing patterns
- Contributes to gamma oscillations
- Modulates theta rhythm
- Affects sharp wave ripples
- Expression alterations: GRIK3 expression changes in AD brain
- Synaptic dysfunction: Contributes to early synaptic loss
- Excitotoxicity: Dysregulated GluK3 signaling contributes to excitotoxic cell death
- Genetic link: GRIK3 polymorphisms associated with epilepsy susceptibility
- Seizure modulation: GluK3 antagonists have anticonvulsant effects
- Status epilepticus: Upregulation after prolonged seizures
¶ Depression and Mood Disorders
- GluK3 in limbic system affects emotional processing
- Antidepressant effects of GluK3 modulation
- Reduced GluK3 in prefrontal cortex in major depression
- Modulates dopaminergic signaling
- Affects levodopa response
- Potential for dyskinesia modulation
Agonists:
- Enhance cognitive function
- Potential neuroprotective effects
Antagonists:
- Antiepileptic properties
- May reduce excitotoxicity
- Treatment of temporal lobe epilepsy
- Cognitive enhancement in early dementia
- Mood disorder intervention
- GluK3 receptor physiology (2020)
- GRIK3 in neurological disorders (2019)
- Kainate receptors in synaptic plasticity (2021)
- GluK3 and epilepsy (2018)
- Kainate receptor pharmacology (2022)
- GluK3 in mood disorders (2020)